Valuation: Medpace Holdings, Inc.

Market Cap 16.49B 14.26B 13.32B 12.22B 22.98B 1,569B 23.34B 156B 61.33B 786B 61.91B 60.56B 2,600B P/E 2026 *
33.6x
P/E 2027 * 30.8x
Enterprise Value 15.68B 13.57B 12.67B 11.62B 21.86B 1,493B 22.21B 149B 58.34B 748B 58.9B 57.61B 2,473B EV / Sales 2026 *
5.5x
EV / Sales 2027 * 5.03x
Free-Float
79.97%
Yield 2026 *
-
Yield 2027 * -
1 day+0.97%
1 week+2.35%
Current month+2.35%
1 month+10.30%
3 months+39.31%
6 months+11.37%
Current year+5.17%
1 week 563.45
Extreme 563.45
594.99
1 month 514.47
Extreme 514.47
677.9
Current year 373
Extreme 373
677.9
1 year 373
Extreme 373
677.9
3 years 227.21
Extreme 227.21
677.9
5 years 126.94
Extreme 126.945
677.9
10 years 21.76
Extreme 21.76
677.9
Manager TitleAgeSince
Chief Executive Officer 69 01/07/1992
Director of Finance/CFO 51 01/08/2021
Chief Tech/Sci/R&D Officer 65 01/09/2017
Director TitleAgeSince
Director/Board Member 74 13/08/2018
Chairman 69 01/07/1992
Director/Board Member 66 13/08/2018
Date Insider Type Main position Quantity % Market Cap.
28/07/26 Sell

Chief Operating Officer

-7,500 0.0263%
28/07/26 Sell

Chief Executive Officer

-3,510 0.0123%
30/06/26 Fiscal year

Director

66 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+0.97%+2.35%+35.99%+122.50% 16.49B
+0.99%+1.78%+5.07%+17.01% 49.47B
+3.71%+9.40%+486.14%+592.61% 43.97B
+5.60%+10.21%+20.85%+73.63% 39.6B
+2.70%+1.57%+32.71%+9.15% 39.29B
+2.21%+6.75%+20.20%+47.53% 32.43B
+2.23%+4.71% - - 16.84B
-0.11%+2.41%+5.03%+20.01% 14.01B
+0.75%+15.04%+79.84%+23.95% 12.77B
+2.07%+0.58%+3.83%-35.14% 12.69B
Average +2.11%+5.74%+76.63%+96.81% 27.76B
Weighted average by Cap. +2.52%+5.85%+100.20%+129.93%

Financials

2026 *2027 *
Net sales 2.85B 2.47B 2.3B 2.11B 3.97B 271B 4.04B 27.03B 10.61B 136B 10.71B 10.47B 450B 3.03B 2.62B 2.45B 2.24B 4.22B 288B 4.29B 28.69B 11.26B 144B 11.37B 11.12B 477B
Net income 503M 435M 406M 372M 700M 47.83B 712M 4.76B 1.87B 23.97B 1.89B 1.85B 79.25B 547M 473M 442M 405M 762M 52.02B 774M 5.18B 2.03B 26.07B 2.05B 2.01B 86.2B
Net Debt -802M -694M -648M -595M -1.12B -76.35B -1.14B -7.6B -2.98B -38.27B -3.01B -2.95B -127B -1.25B -1.08B -1.01B -928M -1.75B -119B -1.77B -11.87B -4.66B -59.73B -4.7B -4.6B -197B
Logo Medpace Holdings, Inc.
Medpace Holdings, Inc. is a scientifically driven, global, full-service clinical contract research organization (CRO) providing phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.
Employees
6,500
Date Price Change Volume
07/08/26 $590.67 +0.97% 136,483
06/08/26 $585.01 -0.47% 148,658
05/08/26 $587.75 +2.20% 246,169
04/08/26 $575.08 +0.31% 227,919
03/08/26 $573.29 -0.66% 249,533
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
590.67USD
Average target price
581.83USD
Spread / Average Target
-1.50%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MEDP Stock